PubMed COVID-19 Clinical Care

No abstract

No abstract

CONCLUSION: SOF/DCV may reduce mortality rate and need for ICU/IMV in patients with COVID-19 while increasing the chance for clinical recovery.

No abstract

A 44-year-old female patient with multiple sclerosis (MS) treated with ocrelizumab was hospitalized with SARS-CoV-2 pneumonia three times over the course of five months, eventually expiring. Viral sequencing of samples from her first and last

Individuals with weaker neutralizing responses show reduced protection with SARS-CoV-2 variants. Booster vaccines are recommended for vaccinated individuals, but the uptake is low. We present the feasibility of utilizing point-of-care tests (POCT) to

CONCLUSIONS: Our study suggests that MDD may increase the susceptibility to COVID-19. Our findings emphasise the need to increase social support and improve mental health intervention networks for people with mood disorders during the pandemic.

This study advocates a novel spatio-temporal method for accurate prediction of COVID-19 epidemic occurrence probability at any time in any Brazil state of interest, and raw clinical observational data have been used. This article describes a novel

CONCLUSION: This study identified high mental health burden, particularly in younger online workers, and associated negative impacts on cognitive function.

CONCLUSION: ANP autonomy and experience enabled continued chest pain assessment and CAD diagnosis via a virtual telephone clinic.